Zogenix Submits Supplemental New Drug Application for FINTEPLA® (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome

NEXT STORY
Senti Bio Awarded Funding from National Cancer Institute (NCI) to Support Development of Logic Gated Allogeneic CAR-NK Cell Therapy SENTI-202 to Treat Acute Myeloid Leukemia
PREV STORY
Orphan Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Onconova Therapeutics to Present Data on a First-in-class Dual Inhibitor of CDK4/6 + ARK5 at the American Association for Cancer Research Annual Meeting 2018

NEWTOWN, Pa., March 15, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

author_avatar
NASDAQ Market News

Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting

CALGARY, Alberta and SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...

author_avatar
NASDAQ Market News

Biomarkers Technologies, Companies and Markets, 2016-2026

Dublin, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets and Companies" ...

author_avatar
NASDAQ Market News